172 related articles for article (PubMed ID: 12800227)
1. Loss of fragile histidine triad protein in human hepatocellular carcinoma.
Zhao P; Song X; Nin YY; Lu YL; Li XH
World J Gastroenterol; 2003 Jun; 9(6):1216-9. PubMed ID: 12800227
[TBL] [Abstract][Full Text] [Related]
2. Expression of fragile histidine triad in primary hepatocellular carcinoma and its relation with cell proliferation and apoptosis.
Nan KJ; Ruan ZP; Jing Z; Qin HX; Wang HY; Guo H; Xu R
World J Gastroenterol; 2005 Jan; 11(2):228-31. PubMed ID: 15633221
[TBL] [Abstract][Full Text] [Related]
3. Expression and Prognostic Role of FHIT, Fibronectin, and PTEN in Hepatocellular Carcinoma.
Zhang MJ; Yan Q; Zhang GL; Wie YH; Yuan WB; Xu W; Huang LF
Clin Lab; 2016 Jul; 62(7):1255-1264. PubMed ID: 28164627
[TBL] [Abstract][Full Text] [Related]
4. Loss of fragile histidine triad expression in colorectal carcinomas and premalignant lesions.
Hao XP; Willis JE; Pretlow TG; Rao JS; MacLennan GT; Talbot IC; Pretlow TP
Cancer Res; 2000 Jan; 60(1):18-21. PubMed ID: 10646844
[TBL] [Abstract][Full Text] [Related]
5. FHIT mRNA and protein expression in hepatocellular carcinoma.
Kannangai R; Sahin F; Adegbola O; Ashfaq R; Su GH; Torbenson M
Mod Pathol; 2004 Jun; 17(6):653-9. PubMed ID: 15060557
[TBL] [Abstract][Full Text] [Related]
6. Effect of fragile histidine triad gene transduction on proliferation and apoptosis of human hepatocellular carcinoma cells.
Xu RH; Zheng LY; He DL; Tong J; Zheng LP; Zheng WP; Meng J; Xia LP; Wang CJ; Yi JL
World J Gastroenterol; 2008 Jun; 14(23):3754-8. PubMed ID: 18595145
[TBL] [Abstract][Full Text] [Related]
7. Inverse correlation of aberrant expression of fragile histidine triad (FHIT) protein with cyclin D1 protein and prognosis in Chinese patients with cholangiocarcinoma.
Zhao P; Lu Y; Zhong M; Liu L; Li B
Acta Oncol; 2008; 47(8):1557-63. PubMed ID: 18618300
[TBL] [Abstract][Full Text] [Related]
8. Loss of fragile histidine triad expression in colorectal carcinoma.
Zhao P; Lu Y; Hu Y; Zhong M; Li Z; Li X
Zhonghua Bing Li Xue Za Zhi; 2002 Apr; 31(2):124-7. PubMed ID: 12419158
[TBL] [Abstract][Full Text] [Related]
9. [Abnormal expression of fragile histidine triad (FHIT) and Mut S homolog 2 (MSH2) proteins in human sporadic colorectal carcinoma and their clinical significance].
Yao CC; Lin CY; Hu MB
Ai Zheng; 2004 Mar; 23(3):310-6. PubMed ID: 15025965
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of fragile histidine triad expression in tumors from saudi arabia: a tissue microarray analysis.
Bavi P; Jehan Z; Atizado V; Al-Dossari H; Al-Dayel F; Tulbah A; Amr SS; Sheikh SS; Ezzat A; El-Solh H; Uddin S; Al-Kuraya K
Cancer Epidemiol Biomarkers Prev; 2006 Sep; 15(9):1708-18. PubMed ID: 16985034
[TBL] [Abstract][Full Text] [Related]
11. [Clinicopathological significance of aberrant methylation of the fragile histidine triad gene in patients with hepatocellular carcinoma].
Sun Y; Geng XP; Zhu LX; Xiong QR; Qian YB; Dong GY; Li XM
Zhonghua Wai Ke Za Zhi; 2006 May; 44(9):609-12. PubMed ID: 16784654
[TBL] [Abstract][Full Text] [Related]
12. Expression of abnormal transcripts of the FHIT (fragile histidine triad) gene in ovarian carcinoma.
Mandai M; Konishi I; Kuroda H; Nanbu K; Matsushita K; Yura Y; Hamid AA; Mori T
Eur J Cancer; 1998 Apr; 34(5):745-9. PubMed ID: 9713284
[TBL] [Abstract][Full Text] [Related]
13. Aberrant fragile histidine triad gene transcripts in primary hepatocellular carcinoma and liver cirrhosis.
Gramantieri L; Chieco P; Di Tomaso M; Masi L; Piscaglia F; Brillanti S; Gaiani S; Valgimigli M; Mazziotti A; Bolondi L
Clin Cancer Res; 1999 Nov; 5(11):3468-75. PubMed ID: 10589760
[TBL] [Abstract][Full Text] [Related]
14. Low expression of FHIT and PTEN correlates with malignancy of gastric carcinomas: tissue-array findings.
Zheng H; Takahashi H; Murai Y; Cui Z; Nomoto K; Tsuneyama K; Takano Y
Appl Immunohistochem Mol Morphol; 2007 Dec; 15(4):432-40. PubMed ID: 18091387
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the fragile histidine triad gene in hepatitis C virus-associated hepatocellular carcinoma.
Zekri AR; Bahnassy AA; Hafez M; El-Shehaby AM; Sherif GM; Khaled HM; Zakhary N
J Gastroenterol Hepatol; 2005 Jan; 20(1):87-94. PubMed ID: 15610452
[TBL] [Abstract][Full Text] [Related]
16. Decreased fragile histidine triad gene protein expression is associated with worse prognosis in oral squamous carcinoma.
Guerin LA; Hoffman HT; Zimmerman MB; Robinson RA
Arch Pathol Lab Med; 2006 Feb; 130(2):158-64. PubMed ID: 16454554
[TBL] [Abstract][Full Text] [Related]
17. Loss of FHIT protein expression correlates with disease progression and poor differentiation in gastric cancer.
Rocco A; Schandl L; Chen J; Wang H; Tulassay Z; McNamara D; Malfertheiner P; Ebert MP
J Cancer Res Clin Oncol; 2003 Feb; 129(2):84-8. PubMed ID: 12669232
[TBL] [Abstract][Full Text] [Related]
18. Abnormal fragile histidine triad (FHIT) expression in advanced cervical carcinoma: a poor prognostic factor.
Krivak TC; McBroom JW; Seidman J; Venzon D; Crothers B; MacKoul PJ; Rose GS; Carlson JW; Birrer MJ
Cancer Res; 2001 Jun; 61(11):4382-5. PubMed ID: 11389064
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological significance of FHIT protein expression in gastric adenocarcinoma patients.
Zhao P; Liu W; Lu YL
World J Gastroenterol; 2005 Sep; 11(36):5735-8. PubMed ID: 16237777
[TBL] [Abstract][Full Text] [Related]
20. Expression of Fhit, Mlh1, and P53 protein in human gallbladder carcinoma.
Koda M; Yashima K; Kawaguchi K; Andachi H; Hosoda A; Shiota G; Ito H; Murawaki Y
Cancer Lett; 2003 Sep; 199(2):131-8. PubMed ID: 12969785
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]